Aug 2026· ChemistrySelect· Vol 11· 0 citations· 13 references
TL;DR
This review summarizes recent advances in CRISPR‐based diagnostics, focusing on Cas12, Cas13, and Cas14, along with key platforms including SHERLOCK, DETECTR, and FELUDA, and discusses their integration with POC technologies such as microfluidic devices, lateral‐flow assays, and smartphone‐based detection systems.
Abstract
Conventional molecular diagnostics, particularly polymerase chain reaction (PCR), remain the gold standard for pathogen detection but are often unsuitable for rapid point‐of‐care (POC) testing because they require specialized equipment and laboratory infrastructure. CRISPR‐Cas systems have emerged as powerful alternatives, offering rapid, accurate, and programmable molecular diagnostics with strong potential for decentralized healthcare. This review summarizes recent advances in CRISPR‐based diagnostics, focusing on Cas12, Cas13, and Cas14, along with key platforms including SHERLOCK, DETECTR, and FELUDA. We discuss their integration with POC technologies such as microfluidic devices, lateral‐flow assays, and smartphone‐based detection systems. Their performance is compared with PCR in terms of sensitivity, specificity, turnaround time, and operational requirements. CRISPR‐based assays demonstrate PCR‐comparable accuracy while enabling isothermal amplification and results within 30–60 minutes. These technologies have supported rapid lateral‐flow testing and received emergency authorization from regulatory agencies, including the U.S. Food and Drug Administration (FDA) and the Indian Council of Medical Research (ICMR), for SARS‐CoV‐2 detection. Despite these advances, challenges such as multiplex detection, reagent stability under ambient conditions, and large‐scale clinical validation remain. Continued improvements in these areas will be essential for translating CRISPR diagnostics into widely accessible, reliable molecular testing at the point of care.
This review provides a structured overview of current LAMP-CRISPR platforms and highlights key technological considerations for translating rapid microbial pathogen detection from laboratory research to real-world applications.
Yi Xu, Xiao-Jiao He, Tian-Le Xu· Journal of Applied Microbiol...· 0 citations
A comprehensive evaluation of current applications demonstrates the efficacy of CRISPR-Cas12b-based diagnostics across diverse pathogens, including viruses, bacteria, and parasites, with a specific focus on its integration with isothermal amplification techniques.
Jiang-Ying Li, Xue-Yong Zhang· Current Issues in Molecular...· 0 citations
Early diagnosis markedly improves therapeutic efficacy, recovery, and disease control. Microfluidic platforms based on isothermal nucleic acid amplification enable sensitive, rapid, and low‐volume detection of disease markers. This review provides a critical analysis of the integration of isothermal amplification tec...
T. Trinh, V. Dinh, Hanh An Nguyen et al.· Advanced Materials & Technol...· 0 citations
CATNAP (Cas trans -nuclease detection of amplified products), a method that integrates isothermal linear DNA amplification with Cas12a detection in a single reaction, bridges the sensitivity gap in CRISPR diagnostics while maintaining simplicity, making accurate disease detection more accessible in resource-limited setti...
S. Sinan, Remy M. Kooistra, Karunya Rajaraman et al.· 0 citations
This work presents a broadly applicable one-pot detection strategy termed mutant scaffold-mediated RPA-CRISPR/Cas12a (MS-CRISPR), and introduces rationally designed point mutations into the crRNA scaffold to moderately attenuate Cas12a activation and cleavage kinetics.
Qing-Yang Jiang, Rui-Quan Xu, Zhi-Xin Lin et al.· Proceedings of the National...· 0 citations
An integrated framework that connects five coupled design layers with five levels of translational evidence shifts the evaluation of CRISPR diagnostics from isolated analytical performance toward evidence-based workflow co-design.
Heng-Yu Wang, Mei-You Chen, Qiu-Run He et al.· ACS Sensors· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.